Medtronic sponsors research aimed at improving patient outcomes ADDISON, Texas, May 28, 2020 (GLOBE NEWSWIRE) — Jordan R.H. Hoffman, MD, Assistant Professor in Cardiac Surgery at Vanderbilt University School of Medicine in Nashville, TN., has received the O.H. Frazier Award in MCS Translational Research sponsored by Medtronic and administered by […]
Coronary/Structural Heart
PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients
PhaseBio receives clearance of IND application from U.S. FDA under Coronavirus Treatment Acceleration Program (CTAP) “VANGARD” trial will assess the efficacy and safety of PB1046 in hospitalized COVID-19 patients at high risk for rapid clinical deterioration and acute respiratory distress syndrome Based on FDA feedback, PhaseBio believes that positive, clearly […]
Neovasc Has Filed for CE Mark for Tiara TA Transapical Mitral Valve Replacement System
Less invasive approach provides hope for the millions of patients that suffer from leaky mitral valves VANCOUVER and MINNEAPOLIS, MN, May 27, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive […]
CARMAT Announces the First Implantation of Its Total Artificial Heart in Denmark
This implant, performed at Rigshospitalet in Copenhagen, marks the resumption of the recruitment in the PIVOTAL study and brings the total number of patients to thirteen CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people […]
Amarin Supports Trial to Investigate the Effects of VASCEPA® (icosapent ethyl) in the Treatment of COVID-19
DUBLIN, Ireland and BRIDGEWATER, N.J., May 21, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), today announced support for a clinical trial to investigate the effects of icosapent ethyl (IPE) (VASCEPA®) on inflammatory biomarkers and other patient outcomes in individuals with COVID-19. The trial is sponsored by the Canadian Medical and […]
Mentice Expands its Coronary Product Portfolio With an Advanced Software Solution for Coronary Interventions
Coronary Advanced to Help Fellows and Attending Interventional Cardiologists to Perfect Skills in Complex Scenarios STOCKHOLM, May 21, 2020 /PRNewswire/ — Mentice AB (STO: MNTC), a world leader in high-fidelity endovascular simulation introduces Coronary Advanced for select VIST® platforms. Following the introduction of Coronary Essentials and Coronary Intermediate, Coronary Advanced is the most […]
PROTECT III Study Shows Placing Impella Prior to High-Risk PCI is Associated with Lower Mortality Compared to Bailout PCI
Women Disproportionately Impacted with Bailout DANVERS, Mass.–(BUSINESS WIRE)–Data from more than 1,000 patients presented during the virtual 2020 Society for Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions demonstrates Impella reduced in-hospital mortality when placed before a non-emergent percutaneous coronary intervention (PCI) is performed. As detailed in the online presentation, the research found, in […]
Mezzion Pharma’s new orphan drug udenafil improved ventricular function measured by myocardial performance index (MPI) in adolescents with congenital single ventricle heart disease (SVHD) – Further results from the pivotal 400-subject Phase 3 FUEL Trial
Mezzion Pharma files new patent applications to cover globally this important MPI advancement, a unique new finding as a result of treatment of SVHD patients with udenafil SEOUL, South Korea, May 18, 2020 /PRNewswire/ — Mezzion Pharma Co. Ltd. today announced that analysis of data from its Phase 3 FUEL trial showed statistically significant positive […]
Corindus Announces New Clinical Data Showing 20 Percent Reduction in Patient Radiation Exposure with Robotic-assisted Intervention
Clinical evidence shows significant patient radiation reduction with CorPath® GRX Vascular Robotic System WALTHAM, Mass.–(BUSINESS WIRE)–Corindus, a Siemens Healthineers Company and leading developer of precision vascular robotics, announced today that Circulation: Cardiovascular Interventions has published clinical results from a comparative study between robotic percutaneous coronary intervention (PCI) and manual PCI. Findings from the study […]
Medtronic Congenital Heart Disease Studies Show Strong 10-Year Performance for Melody Transcatheter Pulmonary Valve and Primary Results from the Harmony Pivotal Trial
Milestone Results Presented as Late-Breaking Clinical Science at SCAI 2020 DUBLIN, May 15, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT) today announced results from two late-breaking clinical trials presented virtually at the 2020 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions. Ten-year outcomes from the Melody™ Transcatheter Pulmonary Valve (TPV) Therapy […]



